25
Growth Score
pts
Heat Score
-22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
180 Therapeutics is a clinical stage drug discovery and development company.
About the Company
180 Therapeutics is a therapeutics company that is focused on the development of novel biologic therapies for the treatment of fibrosis. It develops anti-TNF therapeutics. It mainly focuses on fibrosis in the liver, lung, and musculoskeletal system.
180 Therapeutics is focused on the research and evaluation of human disease tissues to understand
how scarring and fibrosis occurs to produce diseases.
180 Therapeutics was founded by Glenn Larsen and is headquartered in Cambridge, Massachusetts.
